Magusan, Sitti Alia G.
HRN: 24-36-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2025
MUPIROCIN 2%, 15G (TUBE)
03/24/2025
03/31/2025
TOPICAL
0.5mg
BID
BFC
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes